|
Ka: acid ionization constant, a
measure of the degree to which an acid ionizes in solution and a constant which
has no units. The negative log of the Ka value is the pKa which is also
expressed without units.
KA: a pharmacokinetic term meaning the association constant for the
binding of a drug to proteins given in units of L/mole.
KA:
the equilibrium dissociation constant for an agonist
binding to receptors.
ka: a pharmacokinetic term meaning the absorption rate constant
given in units of hr-1.
KB:
the equilibrium dissociation constant for an antagonist
binding to receptors.
Kd: also written as KD, the dissociation equilibrium
constant for an agonist.
kDa:
kilodaltons, a unified atomic mass unit for
measuring the molecular weight of proteins.
KD: the
dissociation equilibrium constant for an agonist.
Kainic
acid: a amino acid neurotoxin (its an excitotoxin) originally
obtained from a Japanese seaweed (Digenea simplex) and similar in
structure to the cyclic form of glutamic acid which stimulates
glutamate-sensitive receptors. (See also NMDA and AMPA).
Kainate
receptors: sometimes referred to as non-NMDA receptor, kainate receptors are
CNS receptors sensitive to excitatory amino acids and make up a
separate group of CNS receptors from the NMDA and AMPA receptors although they
are structurally similar. These receptors appear to be essential in synaptic
plasticity and synaptic transmission and play an important role in long-term
potentiation.
Kaliotoxin
(KTX): a single chain 38 amino acid 4kDa polypeptide and a blocker of
voltage-dependent potassium channels which contain Kv1.1 and Kv1.3
subunits. Kaliotoxin, which shows sequence homology with
charybdotoxin,
noxiustoxin and iberiotoxin, is
found in the venom of the scorpion (Androctonos mauretanicus) and is
used as a pharmacological tool to elucidate the molecular pharmacology
of the high conductance Ca2+-activated K+ channels. It interacts with the channel in a one to one manner on the
outside of the channel.
Kallidin
I: also known as bradykinin, a physiologically active
polypeptide which is formed from a blood plasma globulin (bradykininogen which
is also known as kallidin II) and which mediates inflammatory responses,
increases vasodilation and causes contraction of smooth muscle.
Kallikrein:
also known as kininogenin, an enzyme present in blood plasma
(plasma kallikrein EC 3.4.21.34), lymph, urine, saliva, pancreatic
fluids and tissues (tissue kallikrein) which catalyzes the proteolysis of
bradykininogen (kallidin II) to bradykinin (kallidin I).
Sharma
JN. Interrelationship between the kallikrein-kinin system and hypertension: a
review. Gen Pharmacol (1988) 19(2); 177-187
Kallistatin: a serpin (serine protease inhibitor) and an acidic glycoproteins
which forms a stable complex with tissue kallikrein so inhibiting its
activities. Kallistatin is known to inhibit angiogenesis and tumour growth.
Kanamycins: a family of broad-spectrum aminoglycoside antibiotic (kanamycins
A, B and C) obtained from the soil bacterium Streptomyces kanamyceticus.
They binds to bacterial ribosomes and prevents protein synthesis. They have
been used to treat tuberculosis.
Kaolin-induced
writhing: a method of determining the effects of analgesics by
intraperitoneal injection of a suspension of kaolin which causes the animal to
writhe in pain. A decrease in the number of writhings indicated analgesic
actions of a test compound.
Fujiyoshi
T et al. Kaolin-induced writhing in mice, a new model of possible bradykinin-induced
pain for assessment of analgesic agents. Agents Actions (1989) Jun;27(3-4);
332-4
Kasugamycin: an antibiotic fungicide isolated from bacteria (Streptomyces
kasugaensis) found in a soil sample taken from Kasuga Shrine in Nara, Japan
and named after it. It has been used against Pseudomonas infections but is used
as an agrochemical for the eradication of, for example, Pyricularia oryzae,
a fungal pathogen causing rice blast disease.
Katz,
Bernard (1911-2003): German-born biophysicist and
physiologist who shared the Nobel Prize for Physiology or Medicine in 1970 with
Axelrod and von Euler "for their discoveries concerning the
humoral transmitters in the nerve terminals and the mechanism for their
storage, release and inactivation".
http://www.nobel.se/medicine/laureates/1970/katz-
bio.html
Kava:
a narcotic drug used in ethnopharmacology and commonly
consumed in the islands of the south Pacific including Fiji and Vanuatu. It is
actually the ground up root of a ginger-like shrub Piper methysticum which
is mixed with water and drunk. It contains compounds such as kawain,
methysticum and yangonin which have analgesic and ethanol-like actions. See http://kavaroot.com/aboutkava_frames.htm
kdkd
mouse: a congenic variant of the CBA/Ca mouse which has normal
kidneys at birth but from about week eight postpartum begins to develop
progressive, lethal autoimmune nephritis.
Keratolytic: a compound which promote the softening and shedding of the horny
layers of outer skin by dissolving or breaking down keratin, a protein found in
skin and nails. They are used for the removal of corns and calluses and
examples include salicylic acid, formaldehyde, gluteraldehyde and silver
nitrate.
Ketamine:
an anaesthetic chemically related to phencyclidine and used
clinically intravenously or intramuscularly to induce and maintain anaesthesia
in surgery in both animals and humans. Ketamine produces dissociative anaesthesia
where there is a marked loss of sensation, paralysis, amnesia and analgesia
occurs but consciousness is not actually lost. It acts by inhibiting the polysynaptic
actions of the excitatory neurotransmitter ACh and L-glutamate
in the spinal cord and NMDA in the brain. It is a potent non-competitive
antagonist at NMDA receptors. Ketamine is also a drug of abuse because of its
calming and euphoric effects.
Ketotifen: a 'classic' serotonin antagonist which blocks 5-HT2
receptor and is an H1 histamine receptor antagonist. It has a
stabilizing effect on mast cells rather like cromoglicate. It is used
clinically to treat asthma but is not the drug of choice in this disorder. It
may also be effective in the treatment of topical allergies.
Khat: plant which contains psychostimulants and which is chewed for its
effects. It is used in ethnopharmacology.
Ki: the
equilibrium dissociation constant for a competitive inhibitor of a receptor.
Typically the Ki value of a compound is calculated to determine the
affinity it has to a particular receptor and this compound may be an agonist or
antagonist at this receptor. When calculating Ki values it is common
to used a known radiolabelled agonist or antagonist of the receptor and
determine to what extent the test compound inhibits it binding. This type of
binding assay is commonly employed to determine id a test compound has any
affinity for a particular receptor or receptor subtype and how strong that
affinity is. It can be calculated from the Cheng-Prussof equation:

where
IC50 is the concentration of test compound (ie the unlabelled drug)
which inhibits 50% of the radiolabelled compound binding to the receptor, L is
the concentration of radioactive ligand used and Kd is the affinity
of the radioactive ligand for the receptor. You can
find a PDF from www.graphpad.com
explaining this in more detail here.
Kinases:
a superfamily over a thousand enzymes including isozymes which
account for the activities of about 2-3% of the genes in the human genome. They
are involved in a large number of signal transduction processes in cell growth,
differentiation, metabolism and apoptosis. The most important step in cellular
signal transduction mechanisms is the phosphorylation of amino acid residues
usually tyrosine, serine or threonine in proteins involved in signal
transduction (that is, they transfer phosphate groups from high-energy donors
such as ATP) and this phosphorylation is catalyzed by kinases (and
phosphatases). Kinases are critical cellular components regulating how a cell
respond to exogenous factors such as transmitters, hormones and growth factors.
Diseases such as cancer involve unregulated kinase activity such as
overexpression and/or up-regulation of kinase genes. The largest group of
kinases is the protein kinases and other groups are named after their
substrates and include adenylate kinase, creatinine kinase, pyruvate kinase,
hexokinase, thymidine kinase, nucleotide diphosphate kinase and tyrosine
kinases.
Kinase-linked
receptors: a type of receptor in which the cell signal transduction
mechanism is the phosphorylation of a protein by a kinase (as opposed to the
events at an ion channel-linked receptor, a G protein-coupled receptor or a
enzyme-linked receptor). Examples include receptors for epidermal growth
factor.
Kinase
inhibitors: compounds inhibiting kinases and so disrupting a broad range of
cellular signaling mechanisms involved in growth, differentiation, metabolism
and apoptosis. Several kinase inhibitors are used clinically to treat tumours
and include imatinib to treat chronic myelogenous leukaemia,
gastrointestinal stromal tumours and other malignancies and geftinib,
a selective inhibitor of epidermal growth factor tyrosine kinase, used against
breast and lung tumours (advance or metastatic non-small cell lung cancer).
Kindling:
a method to induce seizures in an animal model of complex-partial
epileptic seizures which has become the most widely studied animal model of
limbic epilepsy. It is also used in the study of neural plasticity. Kindling
can be induced electrically, chemically or audiogenically. There are many
methods of kindling but typically comprise repeated administration of low
intensity pulses of electrical stimulation to the amygdaloid body (amygdaloid
kindling) or hippocampus, chemically by the intracerebral administration of
N-methyl-D-aspartate, pentylenetetrazol or cocaine or audiogenically by
exposure of an animal to high-intensity noise.
McIntyre DC, Poulter MO, Gilby
K. Kindling: some old and some new. Epilepsy Res (2002) 50(1-2); 79-92
Kinins: a family of structurally related polypeptides such as bradykinin
which act locally (they are local hormones or autacoids) to induce
vasodilation and contraction of smooth muscle. Examples include bradykinin.
Kininogen:
an inactive globulin precursor of a plasma kinins. Examples
include bradykininogen.
Klotz
plot: a graphical representation of ligand-receptor binding. It is a
plot of bound ligand vs log free ligand and is used to determine the
appropriate ligand concentration and to determine co-operativity. It is often
used as an alternative to a Scatchard plot and assumes equal and
independent binding sites on a protein.
Klotz
IM, Walker FM, Pivan RB. The binding of organic ions by proteins. J Am Chem Soc
(1946) 68:1486-90
KMD3213:
a selective antagonist of α1A-
adrenoceptors.
Knock
in mouse: a mouse into which a transgene (one from another animal or
species) has been inserted into a specific locus in the mouse's genome. This is
typically carried out to determine the physiological, biochemical and
pharmacological effects of the transgenes or the effects of overexpression of a
particular gene as there is a higher number of them in a knock in animal.
Knock
out mouse: a mouse which has had both alleles of a particular gene replaced
with an inactive allele or disrupted by the insertion of inactive DNA into the
allele so that this gene no longer functions normally. Knock out mice are used
to determine the role of a particular gene by observing the phenotypes of
animals that lack the gene completely.
Conditional
knock out mice are mice in which tissue-specific inactivation of a particular
gene is achieved usually at a specific time point in the animals life and not a
hereditary gene defect. In some cases this can be achieved by the
administration of a drug such as tamoxifen if a tamoxifen responsive
hormone-binding domain of the estrogen receptor under the control of a
tissue-specific promoter is inserted into the transgenic animal.
Konzett-Rossler
method: an in vivo method to determine the activity of
bronchoactive compounds originally developed by Heribert Konzett and Richard
Rossler in 1940. In this method, a tracheal cannula is inserted into the airway
of an anaesthetized and artificially ventilated guinea pig and is connected to
a spirometer in order to measure changes in the volume of the trachea and
bronchioles. The actions of bronchodilators and bronchoconstrictors can be
observed as changes in air volume within the trachea and bronchioles.
Konzett
H, Roessler R. Versuchsanordnung zu Untersuchungen an der Bronchialmuskulatur.
Arch Exp Path Pharmakol (1940) 195; 71-74 (written in German)
Kruskall-Wallis
test: a statistical test which is similar to one-way analysis of
variance (ANOVA) used to compare the mean values of three or more sets of data
when the data are chosen from limited sets of values or if the data is not
normally distributed.
Kynurenate:
a compound produced by astrocytes in the brain and an endogenous
antagonist of both the glycine B receptors and (non-competitively at) the
α7 nicotinic receptor. It acts as a broad-spectrum (ie
non-specific) antagonist of ionotropic glutamate receptors such as glutamate
receptors and is used as a pharmacological tool to investigate these
receptors.
Kyneurine:
an amino acid intermediate in the pathway from tryptophan to
nicotinic acid. It is also metabolised to two other components, the neurotoxic
quinolinic acid and the neuroprotective and neuroinhibitory kynurenic acid
(which has antagonist activity at ionotropic glutamate receptors and can
inhibit presynaptic glutamate release). Kyneurine is excreted in small amounts
in the urine as a product of the metabolism of tryptophan.
Ruddick JP et al. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med (2006) Aug 31;8(20):1-27
Kynurenine pathway: a major route of L-tryptophan catabolism which results in the formation of nicotinamide adenine dinucleotide and other neuroactive intermediates such as the neurotoxin, quinolinic acid (which may be associated with inflammatory disease of the brain).
Kyotorphin:
an opioid analgesic dipeptide (L-tyrosyl-L-arginine) which is
synthesized in specific brain regions. It may modulate synaptic transmission
and it appears to directly excites cortical neurons and produces analgesia via
the release of met-enkephalin.
Prasad C. Bioactive cyclic dipeptides. Peptides (1995);16(1):151-64
|